SCHEMBL7988666

SCHEMBL7988666

O=c1nc(-c2cccnc2)[nH]c2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNOT7 Q9UIV1 2/20 0.48
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46
▸ NPY5R Q15761 2/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ GLA P06280 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ UBE2N P61088 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ FSCN1 Q16658 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ P2RX7 Q99572 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ YTHDC1 Q96MU7 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PARN O95453 1/20 0.40
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973628 0.90 SMN1; SMN2 (0.48) CNOT7SMN1; SMN2GLAHTTUBE2N
SCHEMBL7974289 0.90 CNOT7 (0.53) CNOT7NPY5RSMN1; SMN2L3MBTL1KDM4E
SCHEMBL8056886 0.89 SMN1; SMN2 (0.46) CNOT7SMN1; SMN2GLAHTTUBE2N
SCHEMBL7988669 0.89 PARN (0.48) CNOT7SMN1; SMN2GLAHTTUBE2N
SCHEMBL7985337 0.88 CNOT7 (0.48) CNOT7GRIN1GRIN2BROCK2
SCHEMBL7988938 0.88 CNOT7 (0.48) CNOT7GRIN1GRIN2BNPY5RSMN1; SMN2
SCHEMBL7991568 0.86 SMN1; SMN2 (0.45) CNOT7SMN1; SMN2GLAHTTUBE2N
SCHEMBL7987437 0.86 ROCK2 (0.57) CNOT7NPY5RSMN1; SMN2HTTROCK2
SCHEMBL7974015 0.86 PARN (0.49) CNOT7SMN1; SMN2GLAHTTUBE2N
SCHEMBL7991647 0.85 SMN1; SMN2 (0.44) CNOT7GRIN1GRIN2BSMN1; SMN2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback